Citadel Advisors’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5M | Sell |
27,201
-126,866
| -82% | -$7.01M | ﹤0.01% | 2931 |
|
|
2025
Q1 | $7.45M | Sell |
154,067
-10,079
| -6% | -$487K | ﹤0.01% | 1458 |
|
|
2024
Q4 | $6.34M | Buy |
164,146
+159,116
| +3,163% | +$6.14M | ﹤0.01% | 1613 |
|
|
2024
Q3 | $226K | Buy |
+5,030
| New | +$226K | ﹤0.01% | 4529 |
|
|
2024
Q2 | – | Sell |
-45,616
| Closed | -$1.32M | – | 6629 |
|
|
2024
Q1 | $1.32M | Sell |
45,616
-2,248
| -5% | -$65K | ﹤0.01% | 2893 |
|
|
2023
Q4 | $1.1M | Sell |
47,864
-2,932
| -6% | -$67.2K | ﹤0.01% | 2939 |
|
|
2023
Q3 | $847K | Sell |
50,796
-498,198
| -91% | -$8.31M | ﹤0.01% | 3211 |
|
|
2023
Q2 | $15.2M | Sell |
548,994
-615,686
| -53% | -$17M | ﹤0.01% | 953 |
|
|
2023
Q1 | $26.8M | Sell |
1,164,680
-1,190,634
| -51% | -$27.4M | 0.01% | 711 |
|
|
2022
Q4 | $25.7M | Buy |
2,355,314
+1,488,927
| +172% | +$16.2M | 0.01% | 744 |
|
|
2022
Q3 | $7.3M | Buy |
866,387
+792,258
| +1,069% | +$6.68M | ﹤0.01% | 1522 |
|
|
2022
Q2 | $586K | Sell |
74,129
-112,695
| -60% | -$891K | ﹤0.01% | 3975 |
|
|
2022
Q1 | $4.42M | Buy |
186,824
+151,276
| +426% | +$3.58M | ﹤0.01% | 2192 |
|
|
2021
Q4 | $1.22M | Sell |
35,548
-83,156
| -70% | -$2.84M | ﹤0.01% | 3592 |
|
|
2021
Q3 | $2.1M | Sell |
118,704
-284,504
| -71% | -$5.04M | ﹤0.01% | 2953 |
|
|
2021
Q2 | $18.1M | Buy |
403,208
+204,990
| +103% | +$9.2M | ﹤0.01% | 1021 |
|
|
2021
Q1 | $5.13M | Sell |
198,218
-142,604
| -42% | -$3.69M | ﹤0.01% | 2068 |
|
|
2020
Q4 | $6.87M | Buy |
+340,822
| New | +$6.87M | ﹤0.01% | 1505 |
|
|
2020
Q2 | – | Sell |
-469,212
| Closed | -$3.31M | – | 5160 |
|
|
2020
Q1 | $3.31M | Buy |
469,212
+10,119
| +2% | +$71.4K | ﹤0.01% | 1783 |
|
|
2019
Q4 | $3.24M | Buy |
459,093
+42,838
| +10% | +$302K | ﹤0.01% | 1957 |
|
|
2019
Q3 | $5M | Buy |
416,255
+6,408
| +2% | +$77K | ﹤0.01% | 1664 |
|
|
2019
Q2 | $4.96M | Buy |
409,847
+46,120
| +13% | +$558K | ﹤0.01% | 1660 |
|
|
2019
Q1 | $4.57M | Buy |
363,727
+328,965
| +946% | +$4.14M | ﹤0.01% | 1648 |
|
|
2018
Q4 | $234K | Sell |
34,762
-995
| -3% | -$6.7K | ﹤0.01% | 3754 |
|
|
2018
Q3 | $368K | Sell |
35,757
-95,644
| -73% | -$984K | ﹤0.01% | 3371 |
|
|
2018
Q2 | $883K | Buy |
131,401
+82,204
| +167% | +$552K | ﹤0.01% | 2759 |
|
|
2018
Q1 | $423K | Buy |
+49,197
| New | +$423K | ﹤0.01% | 3050 |
|